For your practice
Compounded medications for med spas: what the rules allow
For a med spa the binding question is not which preparation you want — it is who signs the purchase order and whether the product is administered in the room or handed to the patient. Those two answers decide which permits attach to your practice. The supply route built for stock on a shelf runs through a facility registered with FDA as an outsourcing facility under section 503B, and that facility must also hold your own state’s credential.
What actually blocks a med spa?
Not the preparation. The structure of the business.
A med spa is built around product being in the building before a patient is named for it. That is precisely the arrangement federal law declines to exempt: 21 U.S.C. § 353a lifts three federal requirements from a compounded drug only where it is "compounded for an identified individual patient based on the receipt of a valid prescription order." Stock on a shelf has no identified individual patient, so a state-licensed 503A pharmacy supplying it sits outside that exemption whatever the state rule says.
Section 353b is the provision written for the other case. It exempts drugs compounded by a facility registered with FDA as an outsourcing facility and does not require a patient-specific prescription — which is the entire reason that route exists for office stock. Two consequences follow, and they are the whole page.
Who signs the purchase order?
This is the question that separates a med spa from a solo physician practice, and almost no competitor page asks it.
Florida writes it plainly. Fla. Stat. § 499.01(1)(r) requires "a health care clinic establishment permit … for the purchase of a prescription drug by a place of business at one general physical location that provides health care or veterinary services, which is owned and operated by a business entity that has been issued a federal employer tax identification number." The dispositive carve-out sits at § 499.01(2)(r)6: "This paragraph does not apply to the purchase of a prescription drug by a licensed practitioner under his or her license."
Read those two sentences together and the line is sharp. Bought in the physician’s own name, under their own licence: no permit. Bought by the LLC or the PA that holds the EIN: permit required, with a designated qualifying practitioner named on the distribution documents. A med spa is an entity by construction, which is why this lands here and not on the solo-practice page.
Which other states put a permit on the practice?
Two more of the states we have read do, and they key on the same idea from different directions.
Ohio treats it as a licensure question about the business rather than a compounding question. Any entity possessing dangerous drugs at a location needs a terminal distributor of dangerous drugs licence, and dangerous drugs expressly include injectable local anaesthetics and botulinum toxin products. The Board’s guidance for prescriber practices engaged in compounding, updated 1/13/2025, states that "in general, the exemptions to Ohio’s TDDD licensure requirements do not apply if the prescriber practice is engaged in drug compounding."
California keys on the setting. A physician’s own office may be furnished dangerous drugs under Bus. & Prof. Code § 4059.5(d) without a board licence, while a surgical clinic, an accredited outpatient setting or a Medicare-certified ambulatory surgical centre needs a board clinic licence under § 4190. The entity type decides, not the product list.
What does Ohio allow without a licence?
Ohio’s guidance carves out five lower-risk activities that do not trigger licensure, and three of them describe ordinary med spa work: preparing a manufactured dermal filler according to its own labelling; reconstituting a manufactured botulinum toxin product for direct administration, with no intervening steps; and possessing compounded preparations supplied by an Ohio-licensed outsourcing facility.
The caveat in the same document is the operative sentence, and it is the one that catches a practice trying to work ahead of the schedule:
Preparation of such medications in advance of administration requires licensure and compliance with the Board’s compounding rules.
Note the fourth carve-out. Ohio’s own Board names the outsourcing-facility channel as the clean supply route for prescriber-held compounded stock, which is the Board routing office stock away from the 503A route rather than toward it.
Administering or dispensing — which one is your practice doing?
This is the dividing line in every state whose receiving side we have read, and it is under-covered everywhere.
Holding stock to inject in the room is the clean case in most of them. Handing a patient a vial to take home is a different act with a different name, and it is where a practice crosses into dispensing. Florida settles the threshold in its definitions: "The administration shall not be considered dispensing" (Fla. Stat. § 465.003(13)). Cross that line in Florida and § 465.0276(2)(b) makes a registered dispensing practitioner "comply with and be subject to all laws and rules applicable to pharmacists and pharmacies" — and § 465.0276(1)(b) bars such a practitioner from dispensing a Schedule II or Schedule III controlled substance at all, subject to narrow exceptions.
Say "administer in office" and mean it. A supplier who never asks which one you are doing has not understood your question — and a supplier who offers to "compound in advance" is describing something else again, set out at anticipatory compounding compared with office use.
Does your supplier hold your state’s credential?
Federal registration is not the whole answer, and treating it as the whole answer is the most common mistake in this part of the market.
Section 353b is a federal exemption from federal requirements. It preempts no state licensing scheme, and in every state whose receiving side we have read from primary sources, an outsourcing facility must also hold that state’s own credential before it may ship compounded office stock in. In three of them the credential does not come from the board of pharmacy at all: North Carolina registers outsourcing facilities through the Department of Agriculture and Consumer Services, Texas through the Department of State Health Services, and Louisiana through the Board of Drug and Device Distributors, with a Board of Pharmacy controlled-substance licence on top when the product is scheduled.
A reader who checks only the board of pharmacy in those states will conclude no licence is required. That conclusion is wrong, and it is the kind of wrong that surfaces during an inspection rather than during a sales call.
Which state findings change your answer?
Your own state’s rule decides whether the 503A route was ever open to you, and the answers are not similar to each other. Georgia’s rule says non-patient-specific distribution for office use by a practitioner other than a veterinarian "is prohibited," in those words, while expressly leaving outsourcing facilities untouched. Illinois draws its line at sterility rather than at the practitioner. New Jersey bars the practice for human use whether the preparation is sterile or not.
The state-by-state office-use guide carries each rule verbatim with its citation, and the narrower question of what a med spa specifically may keep on the shelf is answered at can a med spa stock compounded drugs. If you want the federal definitions first, start with 503A pharmacies and 503B outsourcing facilities compared. A practice owned by a nurse practitioner has an additional constraint layered on top of all of this; that one is covered for nurse-practitioner-owned practices.
What to bring when you apply
Four things decide how quickly your account can be set up, and all four are answers you already have.
The entity that will purchase — the practice’s legal name and whether the purchase order will be signed by the business or by a named practitioner under their own licence, because in Florida and California that single fact changes which permit applies. The licence of every prescriber who will sign orders, with the state each is licensed in. Whether each preparation will be administered in the office or dispensed to the patient, item by item. And the locations that will hold stock, since more than one of the permits above attaches per physical location rather than per company.
The order those four get asked for in, and what a pharmacy does with each once it has them, is set out at opening an account with a compounding pharmacy.
If you want those four mapped against your state and your product list before you commit to anything, you can apply for an account.